Mono Pharmacare Limited (NSE:MONOPHARMA)
India · Delayed Price · Currency is INR 8.95
0.00 (0.00%)
Sep 10, 2026, 3:19 PM IST
Mono Pharmacare Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 9.84 | 6.98 | 3.63 | 4.18 | 2.45 |
Cash & Short-Term Investments | 9.84 | 6.98 | 3.63 | 4.18 | 2.45 |
Cash Growth | 41.04% | 92.33% | -13.17% | 70.70% | 41.28% |
Accounts Receivable | 749.36 | 418.88 | 315.9 | 218.71 | 55.21 |
Receivables | 749.36 | 418.88 | 315.9 | 218.71 | 55.21 |
Inventory | 424.25 | 553.86 | 422.93 | 326.86 | 47.14 |
Other Current Assets | 29.51 | 110.16 | 59.18 | 61.33 | 36.07 |
Total Current Assets | 1,213 | 1,090 | 801.64 | 611.07 | 140.86 |
Property, Plant & Equipment | 8.94 | 9.72 | 8.86 | 8.26 | 2.97 |
Long-Term Investments | - | - | - | 5.73 | - |
Other Intangible Assets | 0.07 | 0.2 | 0.27 | 0.01 | - |
Long-Term Deferred Tax Assets | 0.78 | 0.45 | 0.12 | 0.53 | - |
Other Long-Term Assets | 0.13 | 0.31 | 0.25 | 0.15 | - |
Total Assets | 1,223 | 1,101 | 811.13 | 625.74 | 143.83 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 292.2 | 187.98 | 96.85 | 69.37 | 33.46 |
Accrued Expenses | 10.4 | 18.66 | 8.04 | 3.91 | 0.98 |
Short-Term Debt | 292.68 | 275.99 | 243.16 | 246.02 | 49.26 |
Current Income Taxes Payable | - | 15.39 | 6.08 | 8.87 | 1.96 |
Other Current Liabilities | 38.15 | 29.74 | 4.04 | 7.43 | 0.28 |
Total Current Liabilities | 633.43 | 527.76 | 358.17 | 335.61 | 85.94 |
Long-Term Debt | 272.34 | 259.61 | 171.25 | 153.25 | 15.14 |
Pension & Post-Retirement Benefits | 1.24 | 0.84 | 0.43 | - | - |
Other Long-Term Liabilities | - | -0 | -0 | - | 0 |
Total Liabilities | 907 | 788.21 | 529.84 | 488.85 | 101.07 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 176.69 | 176.69 | 176.69 | 123.69 | 42.76 |
Additional Paid-In Capital | - | 74.56 | 74.56 | 4.89 | - |
Retained Earnings | - | 60.74 | 29.84 | 8.28 | - |
Comprehensive Income & Other | 138.84 | - | - | - | - |
Total Common Equity | 315.52 | 311.99 | 281.09 | 136.86 | 42.76 |
Minority Interest | 0.35 | 0.35 | 0.19 | 0.03 | - |
Shareholders' Equity | 315.87 | 312.34 | 281.28 | 136.89 | 42.76 |
Total Liabilities & Equity | 1,223 | 1,101 | 811.13 | 625.74 | 143.83 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 565.02 | 535.6 | 414.4 | 399.27 | 64.39 |
Net Cash (Debt) | -555.18 | -528.63 | -410.78 | -395.09 | -61.95 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -31.47 | -29.92 | -26.76 | -69.75 | -12.60 |
Filing Date Shares Outstanding | 14.78 | 17.67 | 17.66 | 12.37 | 4.92 |
Total Common Shares Outstanding | 14.78 | 17.67 | 17.66 | 12.37 | 4.92 |
Working Capital | 579.53 | 562.12 | 443.47 | 275.46 | 54.93 |
Book Value Per Share | 21.35 | 17.66 | 15.92 | 11.06 | 8.69 |
Tangible Book Value | 315.45 | 311.79 | 280.82 | 136.85 | 42.76 |
Tangible Book Value Per Share | 21.34 | 17.65 | 15.90 | 11.06 | 8.69 |
Buildings | - | 4.6 | 4.57 | 4.7 | - |
Machinery | - | 8.94 | 6.86 | 5.19 | 6.43 |